BMRA
BMRA
NASDAQ · Health Care

Biomerica Inc

$2.41
+0.16 (+7.11%)
As of May 16, 2:32 AM ET ·
Financial Highlights (FY 2026)
Revenue
6.82M
Net Income
-6,384,765
Gross Margin
9.4%
Profit Margin
-93.6%
Rev Growth
-34.5%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 9.4% 9.4% 51.4% 51.4%
Operating Margin -96.7% -87.0% 10.2% 10.6%
Profit Margin -93.6% -89.0% 7.4% 6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.82M 10.41M 4.51M 3.72M
Gross Profit 639.6K 976.1K 2.32M 1.91M
Operating Income -6,595,230 -9,057,999 460.4K 394.0K
Net Income -6,384,765 -8,768,943 334.1K 231.1K
Gross Margin 9.4% 9.4% 51.4% 51.4%
Operating Margin -96.7% -87.0% 10.2% 10.6%
Profit Margin -93.6% -89.0% 7.4% 6.2%
Rev Growth -34.5% -34.5% +23.6% -7.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 948.7K 899.3K
Total Equity 4.87M 5.15M
D/E Ratio 0.19 0.17
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -6,483,859 -9,399,765 633.7K 568.5K
Free Cash Flow 271.4K 245.7K